Please login to the form below

Not currently logged in

beyond the pill

This page shows the latest beyond the pill news and features for those working in and with pharma, biotech and healthcare.

Edging Evolution

Edging Evolution

Value created beyond the pill, such as companion diagnostics and devices, are good examples of environmental selection, while me-too products that are not granted market access illustrate the market disfavouring ... The adoption of quality systems from

Latest news

  • Quick Change Quick Change

    Whatever the label, it’s a way of explaining how large changes appear to happen quickly. ... Extended, beyond- the-pill, value propositions that seem difficult are sometimes just syntheses of several things that are already being done in sales support,

  • FDA clears Sandoz and Pear’s Opioid Use Disorder app FDA clears Sandoz and Pear’s Opioid Use Disorder app

    to Pear Therapeutic's first ever 'digital therapeutic' approved by the US regulator last year. ... Its partnership with Pear Therapeutics reflects the growing need for pharma companies to go 'beyond the pill' and offer health systems and patients support

  • The Midas Touch The Midas Touch

    It’s the same goal – successful reproduction – but a different trade-off calculation. ... So too is the push towards business models that create value beyond the pill, as we are beginning to see in chronic diseases like asthma and diabetes.

  • Merck KGaA inks deal for Medisafe adherence app Merck KGaA inks deal for Medisafe adherence app

    The digital programme will be initially rolled out in Brazil, Russia and Mexico. ... Merck has been actively looking into ways to provide‘beyond the pill’ services to patients for some time, and the latest initiative comes shortly after it launched a

  • Merck to pilot digital behavioural change programme Merck to pilot digital behavioural change programme

    Merck last year received UK approval for its mature oral diabetes drug Glucophage (metformin) to treat non-diabetic hyperglycaemia or pre-diabetes and is looking to add ‘beyond the pill’ services ... Chronic diseases are changing the nature of

More from news
Approximately 2 fully matching, plus 33 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 24 partially matching documents found.

Latest from PMHub

  • Connected Patients - Adopting a patient-centric approach in emerging markets

    The concept of patient centricity and putting the patient at the heart of care is being widely adopted by the healthcare industry – the general consensus being that it’s going to ... Many pharmaceutical companies do more now for patients than just

  • Atopic Dermatitis — Going Beyond the Pill

    In the US, physicians typically use the Body Surface Index to assess severity of the disease. ... Around 65% of patients in the US are recognised as suffering from moderate-severe eczema.

  • The Biosimilar Challenge

    The Impact on Pharma. So, what can be done to offset the onslaught? ... We have already seen some originator brands cutting prices and making significant cuts to Beyond the Pill services to enable discounted prices.

  • How to measure marketing success: profit vs ROI

    What we really should be measuring are those long-term account-based metrics – building relationships, looking at the services beyond the pill that we can provide at Pfizer, looking at having ... practically 0% revenue growth for the 6 months prior) to

  • Defining Market Access and the Key to Success

    Where does your brand add value? And what additional value ‘beyond the pill’ you can you provide? ... OUTiCO understands how to access those customers and has the tools to navigate increasingly complex health economies.

More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs


Add my company

We find the soul in the science, the humanity in the data, harnessing the power of creativity to deliver medical...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....